We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App




Automated Immunohematology Approaches Can Resolve Transplant Incompatibility

By LabMedica International staff writers
Posted on 13 Feb 2024
Print article
Image: The IH-500 System is setting new standards immunohematology testing (Photo courtesy of Bio-Rad)
Image: The IH-500 System is setting new standards immunohematology testing (Photo courtesy of Bio-Rad)

The persistent global shortage of donor organs has made the availability of ABO-compatible options a rarity for many hospitals, clinicians, and patients requiring organ transplants. Despite this, advancements in desensitization therapies have made ABO-incompatible organ transplants not only possible but also as successful as compatible transplants. For instance, it has become common for patients with blood group O to receive organs from donors with type A2 blood, a subgroup of the A blood type that expresses fewer antigens. In such cases, the recipient's plasma can be treated using an immune-adsorption column to reduce the anti-A antibody concentration. Alternatively, when this method is not available, plasmapheresis can be utilized to exchange plasma and reduce the titer of anti-A. The reduction in antibody production can also be achieved through standard immunosuppressants and monoclonal antibodies like rituximab.

The titration of relevant ABO blood group antibodies is crucial in managing potentially incompatible organ transplants. The results from titrations help determine the likely success of a transplant procedure with the appropriate immunosuppressive treatment. Additionally, titrations are useful for monitoring antibody production post-transplant and assessing the risk of antibody-mediated rejection later on. Despite its clinical importance, many hospital labs do not routinely perform titration due to its labor-intensive nature, the high skill level required, and the difficulty in interpreting results. Manual titration also suffers from inherent imprecision due to variations in dilution preparation, dilution medium, red blood cell phenotype and the reaction reading which is difficult to standardize.

This issue is further exacerbated by a decrease in new immunohematologists entering the profession, leading to staffing shortages. This, coupled with increased workloads and financial constraints, makes it harder for hospital labs to offer this service and provide timely, definitive results. Consequently, there is a growing need for hematology labs to automate antibody titration to reduce turnaround times and improve result reliability. Automated immunohematology platforms, such as the IH-500 NEXT System from Bio-Rad Laboratories (Hercules, CA, USA), offer a viable solution, enabling local facilities to perform fully automated titrations. The adoption of automation in numerous immunohematology labs has proven successful, allowing them to provide results to doctors within hours on the same day a blood sample is drawn. This quick turnaround is crucial for efficiently allocating donated organs to needy patients and preventing antibody-mediated organ rejection.

Automation also offers greater precision and standardization, as it prevents technical and manual errors. This reduces the need for extensive training and experience, allowing a broader range of staff to perform antibody titrations and analyze the results. This shift can reduce the load on highly skilled specialists, further shortening the time to results. The widespread adoption of automated titration is essential for supporting future transplant services, ensuring that patients receive the critical organ donations they need as soon as possible.

Related Links:
Bio-Rad Immunohematology

Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
New
Myocardial Infarction Test
Savvycheck SensA Heart
New
Borrelia Burgdorferi Test
AESKULISA Borrelia-M

Print article

Channels

Molecular Diagnostics

view channel
Image: The kit includes a container with a film, a compact optical device for attaching a smartphone, and a diagnostic app (Photo courtesy of KIST)

Urine-Based Bladder Cancer Diagnostic Kit to Reduce Need for Unnecessary Cystoscopies

Bladder cancer has a high cure rate of over 90% when detected early, but it is characterized by a recurrence rate of 70%, which requires continuous monitoring. Late-stage detection often results in major... Read more

Microbiology

view channel
Image: The QIAstat-Dx mini gastrointestinal panel has secured U.S. clearance to support year-round outpatient care (Photo courtesy of QIAGEN)

Syndromic Panel Provides Fast Answers for Outpatient Diagnosis of Gastrointestinal Conditions

Acute infectious gastroenteritis is a major cause of outpatient visits and hospitalizations in the U.S., with over 179 million cases estimated annually. Now, a new gastrointestinal panel designed to provide... Read more

Pathology

view channel
Image: The AI tool can search through data and histology images for much more precise information on cancer treatment effectiveness (Photo courtesy of Shutterstock)

AI Tool Analyzes 30K Data Points Per Medical Imaging Pixel in Cancer Search

A new artificial intelligence (AI)-powered tool can detect cell-level characteristics of cancer by analyzing data from very small tissue samples, some as tiny as 400 square micrometers, equivalent to the... Read more

Technology

view channel
Image: Human tear film protein sampling methods (Photo courtesy of Clinical Proteomics. 2024 Mar 13;21:23. doi: 10.1186/s12014-024-09475-8)

New Lens Method Analyzes Tears for Early Disease Detection

Bodily fluids, including tears and saliva, carry proteins that are released from different parts of the body. The presence of specific proteins in these biofluids can be a sign of health issues.... Read more

Industry

view channel
Image: The game-changing immunoassay diagnostics platform delivers results from whole blood sample in 10 minutes (Photo courtesy of SpinChip)

bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics

bioMérieux (Marcy l’Étoile, France) has agreed to acquire SpinChip Diagnostics (Oslo, Norway), the developer of a game-changing immunoassay diagnostics platform. The small benchtop analyzer is well adapted... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.